Industry News

• Abbott enhances pharmaceutical pipeline with acquisition of Facet Biotech  Abbott and Facet Biotech announced a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.
  Abbott March 09, 2010  
• Vaccinating children against flu helps protect wider community  Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well.
  National Institutes of Health March 09, 2010  
• Dr. Rod Markin named interim dean for UNMC College of Medicine  Rod Markin, M.D., Ph.D., has been named interim dean of the University of Nebraska Medical Center College of Medicine effective July 1. The appointment, announced by UNMC Chancellor Harold M. Maurer, M.D., is pending approval.
  University of Nebraska Medical Center March 09, 2010  
• William A. Hawkins, Medtronic Chairman and CEO, receives Distinguished Achievement Award  Medtronic announced William A. Hawkins, chairman and CEO, recently received the Biomedical Engineering Society's Distinguished Achievement Award.
  Medtronic, Inc. March 09, 2010  
• Bristol-Myers Squibb and AstraZeneca announce the commencement of the SAVOR-TIMI 53  BMS and AstraZeneca announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial (SAVOR-TIMI 53), a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA(TM)(saxagliptin).
  Bristol-Myers Squibb Company March 09, 2010  
• Monsanto to break ground on new breeding station in Mississippi  To better serve the needs of southern farmers, Monsanto plans to open a new corn breeding station in Flora, Mississippi. The $2.4 million facility further boosts the company's investment in the South and is a reflection of Monsanto's commitment to continue delivering new high-performing products.
  Monsanto Company March 09, 2010  
• Sanofi-aventis and Merck to create a global leader in Animal Health  Sanofi-aventis and Merck & Co. announced that sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business, to create a global leader in Animal Health.
  Merck & Co., Inc. March 09, 2010  
• Nebraska Pediatric Practice bolsters pediatric care in Nebraska  About 125 physicians have joined the Nebraska Pediatric Practice, the new physician group for the University of Nebraska Medical Center College of Medicine and Children's Hospital & Medical Center.
  University of Nebraska Medical Center March 08, 2010  
• Lilly to acquire European rights to Pfizer Animal Health assets  Elanco, the animal health division of Eli Lilly and Company, announced that Lilly has signed an agreement to acquire the European rights to a portfolio of certain Pfizer Animal Health products.
  Eli Lilly and Company March 08, 2010  
• Humanetics, maker of of anti-radiation drug, sees bigger market  Humanetics, a biotech firm that's developing a drug to protect soldiers and civilians from nuclear fallout, now plans to enter the general medicine market.
  Minneapolis/St. Paul Business Journal March 05, 2010  Katharine Grayson

   (next 10 articles)